AIXTRON SE (LON:0NP9)
13.26
+0.28 (2.15%)
At close: Oct 24, 2025
AIXTRON SE Revenue
AIXTRON SE had revenue of 137.42M EUR in the quarter ending June 30, 2025, with 4.28% growth. This brings the company's revenue in the last twelve months to 633.02M, up 0.59% year-over-year. In the year 2024, AIXTRON SE had annual revenue of 633.16M with 0.52% growth.
Revenue (ttm)
633.02M EUR
Revenue Growth
+0.59%
P/S Ratio
2.41
Revenue / Employee
524.45K EUR
Employees
1,207
Market Cap
1.31B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 633.16M | 3.28M | 0.52% |
| Dec 31, 2023 | 629.88M | 166.71M | 35.99% |
| Dec 31, 2022 | 463.17M | 34.21M | 7.98% |
| Dec 31, 2021 | 428.95M | 159.71M | 59.32% |
| Dec 31, 2020 | 269.25M | 9.62M | 3.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |